South African Medical News

Back to Home Page

Print using browser
Avaxim 160U (hepatitis A vaccine) and Vivaxim (hepatitis A vaccine, typhoid) vaccines.(Sanofi)


Dear Healthcare Professional 

The global supply of Sanofi Pasteur’s hepatitis A-containing vaccines is currently constrained due to unexpected manufacturing issues in the production process. The products concerned are Avaxim® 160U (hepatitis A vaccine, adult presentation) and Vivaxim® (combination of hepatitis A vaccine and typhoid) vaccines.

The constraint has led to supply shortages in various markets, including South Africa. It is not currently known when the situation will return to normal, Sanofi will keep the market informed.

If you have any further queries, please contact your Sanofi representative or the Customer Services Department on the toll-free line 0800 601 228.

  • This is a drug - read the leaflet carefully before use 
  • Ask your doctor or pharmacist for further information.
For full prescribing information refer to the package insert approved by the medicines regulatory authority.

Sanofi Pasteur is committed to resolving this situation and to resuming the release of its hepatitis A-containing vaccines in a timely manner and deeply regrets any inconvenience that this may cause in the interim.

Sanofi Pasteur thank you for your patience and understanding and assure you of their commitment to service excellence at all times.

Sanofi-aventis south africa (proprietary) limited – Private Bag X207, Midrand, 1683 – South Africa

You need to be logged in to see more details. Register Now!

Click here to visit the Sanofi website.....
Contact: Avinashine Ramlakhan, Product Manager
Telephone: +27 (0) 11 256 3700
Date: Tuesday, July 23, 2019